Both PET/CT and whole-body MRI do a good job of detecting metastatic disease in breast cancer patients, with each modality demonstrating strengths and weaknesses.
Dear AuntMinnie Member,
Both PET/CT and whole-body MRI do a good job of detecting metastatic disease in breast cancer patients, with each modality demonstrating strengths and weaknesses.
A German group pitted the modalities against each other in a matchup designed to help visualize lesions that may be malignant but not enlarged. We're featuring the article this week in our Molecular Imaging Digital Community.
The group found that PET/CT was better at detecting metastatic lesions in areas like the lymph nodes that were not pathologically enlarged. But whole-body MRI -- at both 1.5 and 3-tesla field strengths -- excelled in finding metastases in areas like the liver, bone, and brain.
So which modality should clinicians order? Read for yourself by clicking here, or visit our Molecular Imaging Digital Community at http://molecular.auntminnie.com/.
In other news, we revisit the topic of 256-slice CT in our CT Digital Community. The work-in-progress technology has been generating interest due to its potential application in cardiac imaging, but the Japanese researcher who is spearheading the R&D work believes it will also be beneficial for brain imaging. Find out why by clicking here.
